Kidneys Home > Omontys Drug Interactions

In February 2013, Omontys was pulled from the market (all of the product was recalled) to investigate reports of dangerous allergic reactions, including fatal anaphylactic reactions, which appear to be occurring more frequently than anticipated. This medication will not be available until further notice.
 
Omontys® (peginesatide) is a medication approved to treat anemia caused by chronic kidney failure. At this time, there are no known drug interactions with Omontys. It is important to understand that specific studies to check for interactions with Omontys have not been performed, and it is possible that there are potential reactions that are currently unknown.
 
Omontys should not be combined with epoetin alfa (Epogen®, Procrit®) or darbepoetin alfa (Aranesp®). These medications are quite similar, with a few important differences, and using them together would increase the risk for side effects.
 
Due to the general lack of information at this time, make sure to check with your healthcare provider and pharmacist before combining Omontys with other medications, as new information on drug interactions may become available at any time.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics & Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.